A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Multiple-Ascending Doses of RO7303509 in Patients with Systemic Sclerosis

Status

Completed

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2022-502981-26-00

Acronym

GA43360

Enrollment

Registered

2024-02-19

Start date

2022-06-27

Completion date

2025-07-08

Last updated

2025-03-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Systemic Sclerosis

None listed

Sex/Gender

All

Age

18 Years to No maximum

Belgium, France, Germany, Poland, Portugal, Spain

None listed

Source: EU CTIS · Data processed: Feb 4, 2026